Latvia has received the first shipment of Comirnaty vaccines (Pfizer/BioNTech) intended for children, as confirmed by Minister of Health Daniels Pavļuts on Twitter.
He says the orange-marked vaccine bottles for children are in Latvia. This means vaccination of 5-11 year old children can commence in the second half of the week.
National Health Service Vaccination Project Office representative Zaiga Barvida reports having received 54 000 vaccine doses.
As previously reported, vaccination of children of the age of 5 to 11 years will be performed using specially configured Comirnaty vaccines. These vaccines are marked differently than the vaccines used to vaccinate adults and contain a smaller dose.
The minister previously said child vaccination should remain voluntary.
As previously reported, European Medicines Agency has registered Comirnaty vaccine to be used for children aged 5 to 11 years. Approval was provided based on research data, which suggests the benefits from vaccination outweigh the risks. 3 082 children participated in the research. Comirnaty is the only vaccine in Europe that is available to vaccinate children under the age of 12 years.
Read also: Latest Covid-19 cases in Baltics. 271 in Latvia, 828 in Lithuania, 317 in Estonia